BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 14654301)

  • 1. Fundamental molecular mechanism of the CNS effects of TRH.
    Yarbrough GG
    Trends Pharmacol Sci; 2003 Dec; 24(12):617-8. PubMed ID: 14654301
    [No Abstract]   [Full Text] [Related]  

  • 2. The thyrotropin-releasing hormone (TRH)-immune system homeostatic hypothesis.
    Kamath J; Yarbrough GG; Prange AJ; Winokur A
    Pharmacol Ther; 2009 Jan; 121(1):20-8. PubMed ID: 19000920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone (TRH) in the neuroaxis: therapeutic effects reflect physiological functions and molecular actions.
    Yarbrough GG; Kamath J; Winokur A; Prange AJ
    Med Hypotheses; 2007; 69(6):1249-56. PubMed ID: 17553626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats.
    Heuer H; Schäfer MK; O'Donnell D; Walker P; Bauer K
    J Comp Neurol; 2000 Dec; 428(2):319-36. PubMed ID: 11064370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic distribution of thyrotropin-releasing hormone receptors in the African lungfish Protopterus annectens.
    Pack AM; Caine SB; Winokur A; Manaker S; Fishman AP
    J Comp Neurol; 1989 Sep; 287(1):19-27. PubMed ID: 2551933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of thyrotropin-releasing hormone receptors by adenovirus-mediated gene transfer reveals that thyrotropin-releasing hormone desensitization is cell specific.
    Falck-Pedersen E; Heinflink M; Alvira M; Nussenzveig DR; Gershengorn MC
    Mol Pharmacol; 1994 Apr; 45(4):684-9. PubMed ID: 8183247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone analogs.
    Colson AO; Gershengorn MC
    Mini Rev Med Chem; 2006 Feb; 6(2):221-6. PubMed ID: 16472189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin releasing hormone (TRH): possible physiological functions not related to the neuroendocrine system.
    Horita A; Kalivas PW; Simasko SM
    Rev Pure Appl Pharmacol Sci; 1983; 4(2):111-37. PubMed ID: 6142504
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyrotropin-releasing hormone.
    Jackson IM
    N Engl J Med; 1982 Jan; 306(3):145-55. PubMed ID: 6798440
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the extracellular loops of the thyrotropin-releasing hormone receptor: evidence for an initial interaction with thyrotropin-releasing hormone.
    Perlman JH; Colson AO; Jain R; Czyzewski B; Cohen LA; Osman R; Gershengorn MC
    Biochemistry; 1997 Dec; 36(50):15670-6. PubMed ID: 9398295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
    del Camino D; Barros F; Pardo LA; de la Peña P
    Biochemistry; 1997 Mar; 36(11):3308-18. PubMed ID: 9116009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.
    Thirunarayanan N; Nir EA; Raaka BM; Gershengorn MC
    Neuropsychopharmacology; 2013 May; 38(6):950-6. PubMed ID: 23303050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system effects of thyrotropin-releasing hormone and its analogues: opportunities and perspectives for drug discovery and development.
    Prokai L
    Prog Drug Res; 2002; 59():133-69. PubMed ID: 12458966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone induced thermogenesis in Syrian hamsters: site of action and receptor subtype.
    Shintani M; Tamura Y; Monden M; Shiomi H
    Brain Res; 2005 Mar; 1039(1-2):22-9. PubMed ID: 15781042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin-releasing hormone (TRH) analogues that exhibit selectivity to TRH receptor subtype 2.
    Kaur N; Lu X; Gershengorn MC; Jain R
    J Med Chem; 2005 Sep; 48(19):6162-5. PubMed ID: 16162016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What does brain thyrotropin-releasing hormone do?
    Prange AJ; Utiger RD
    N Engl J Med; 1981 Oct; 305(18):1089-90. PubMed ID: 6116193
    [No Abstract]   [Full Text] [Related]  

  • 18. Two novel thioamide analogues of TRH with selective activity on CNS.
    Alexandrová M; Strbák V; Kruszynski M; Zboinska J; Kupryszewski G
    Gen Physiol Biophys; 1991 Jun; 10(3):287-97. PubMed ID: 1655558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3H-(3MeHis2)thyrotropin releasing hormone receptors in rat central nervous system.
    Simasko SM; Horita A
    Proc West Pharmacol Soc; 1982; 25():75-8. PubMed ID: 6289346
    [No Abstract]   [Full Text] [Related]  

  • 20. Caffeine inhibits the binding of thyrotropin-releasing hormone in GH4C1 pituitary cells.
    Karhapää L; Törnquist K
    Biochem Biophys Res Commun; 1995 May; 210(3):726-32. PubMed ID: 7539257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.